Kumai Y et al. |
Reversible Cerebral Vasoconstriction Syndrome After Heart Transplantation: A Case Report. |
2017 |
Transplant. Proc. |
pmid:29198694
|
Ricordi C et al. |
Donor bone marrow cell infusion without recipient cytoablation induces acceptance of rat islet allografts. |
1994 |
Transplant. Proc. |
pmid:7527967
|
Tsugita M et al. |
Hepatocytes or liver nonparenchymal cells plus FK 506 prolong liver xenograft survival. |
1994 |
Transplant. Proc. |
pmid:7527969
|
Kobayashi M et al. |
Production of monoclonal antibody against recombinant human FKBP-12 and subcellular localization of FKBP-12 in human mononuclear and polymorphonuclear cells. |
1993 |
Transplant. Proc. |
pmid:7679832
|
Kuroki H et al. |
Effect of FK 506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival. |
1993 |
Transplant. Proc. |
pmid:7679833
|
Machida M et al. |
Effect of temperature and hematocrit on plasma concentration of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721266
|
Nakajima H and Oka T |
The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506. |
1996 |
Transplant. Proc. |
pmid:8623224
|
Ko S et al. |
Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8623229
|
McDiarmid S et al. |
One hundred children treated with tacrolimus after primary orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636564
|
Toda F et al. |
Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11119909
|
Videla CO |
Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715995
|
Ohara K et al. |
Toxicologic evaluation of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689910
|
Mazali FC et al. |
Posttransplant diabetes mellitus: incidence and risk factors. |
2008 |
Transplant. Proc. |
pmid:18455010
|
Stratta RJ et al. |
FK 506 induction and rescue therapy in pancreas transplant recipients. |
1996 |
Transplant. Proc. |
pmid:8623492
|
O'Neill EA et al. |
The FK 506-sensitive nature of the interleukin-2 promoter is derived from a specific array of multiple regulatory elements. |
1991 |
Transplant. Proc. |
pmid:1721298
|
Birk PE et al. |
Preliminary experience with FK 506 in pediatric renal transplant recipients: a single-center report. |
1996 |
Transplant. Proc. |
pmid:8623493
|
Watanabe K et al. |
Donor bone marrow cell infusion is effective in inducing tolerance in dogs treated with fractionated lymphoid irradiation and FK506. |
2000 |
Transplant. Proc. |
pmid:11120286
|
Nelson PA et al. |
Effect of immunosuppressive drugs on cytokine gene transcription studied by message amplification phenotyping (MAPPing) polymerase chain reaction. |
1991 |
Transplant. Proc. |
pmid:1721299
|
Schulz T et al. |
Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin. |
1998 |
Transplant. Proc. |
pmid:9636623
|
Ciancio G et al. |
Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636624
|
Perrella A et al. |
Cytomegalovirus infection after liver transplantation: prophylaxis and preemptive treatment--a single-center experience. |
2010 |
Transplant. Proc. |
pmid:20534267
|
Watanabe Y et al. |
The expression of nonmuscle myosin heavy chain in rat renal transplantation. |
1999 |
Transplant. Proc. |
pmid:10578260
|
Meçule A et al. |
Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors. |
2010 |
Transplant. Proc. |
pmid:20534290
|
Alloway R et al. |
Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen. |
2005 |
Transplant. Proc. |
pmid:15848559
|
Tellis V et al. |
No-load sirolimus with tacrolimus and steroids is safe and effective in renal transplantation. |
2005 |
Transplant. Proc. |
pmid:15848571
|
Chen JS et al. |
Effect of CYP3A5 genotype on renal allograft recipients treated with tacrolimus. |
2009 |
Transplant. Proc. |
pmid:19545678
|
Akbas SH et al. |
Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients. |
2004 Jan-Feb |
Transplant. Proc. |
pmid:15013308
|
Bakar F et al. |
Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus. |
2009 |
Transplant. Proc. |
pmid:19545695
|
Cabello M et al. |
Pharmacokinetics of once- versus twice-daily tacrolimus formulations in kidney transplant patients receiving expanded criteria deceased donor organs: a single-center, randomized study. |
2010 |
Transplant. Proc. |
pmid:20970603
|
Morris RE et al. |
A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection. |
1990 |
Transplant. Proc. |
pmid:1697111
|
Marcén R et al. |
Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation. |
2010 |
Transplant. Proc. |
pmid:20970609
|
Woo J et al. |
Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats. |
1990 |
Transplant. Proc. |
pmid:1697112
|
Wynn C et al. |
High level of TGF-beta in organ transplantation might be due to rejection rather than calcineurin inhibitor medication. |
2002 |
Transplant. Proc. |
pmid:12176408
|
Alessiani M et al. |
Total orthotopic small bowel transplantation in swine under FK 506. |
1994 |
Transplant. Proc. |
pmid:7518148
|
Date K et al. |
Effect of FK 506 on graft survival in rat small intestinal allografts. |
1992 |
Transplant. Proc. |
pmid:1376516
|
Murase N et al. |
Bone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease. |
1995 |
Transplant. Proc. |
pmid:7533386
|
Ishibashi M et al. |
Effect of FK 506 on generation of activated macrophages invading rejected skin allografts in rats: discrepancy of in vitro versus in vivo effects. |
1991 |
Transplant. Proc. |
pmid:1721330
|
Mitsuoka N et al. |
Cytokinic character of graft infiltrate versus peripheral blood lymphocytes during calcineurin inhibitor-resistant small bowel transplantation in rats. |
2003 |
Transplant. Proc. |
pmid:12591532
|
Charco R et al. |
CD28 regulation in liver transplant recipients treated with two different immunosuppressive regimens. |
1999 |
Transplant. Proc. |
pmid:10616508
|
Hoshinaga K et al. |
Regimen of tacrolimus-based immunosuppression with basiliximab, mycophenolate mofetil, and low-dose steroid reduces acute rejection in kidney transplants. |
2005 |
Transplant. Proc. |
pmid:15919457
|
Yoshimura N et al. |
Safety analysis after tacrolimus immunosuppression in renal transplant recipients in Japan: 5-year results in >1500 patients. |
2005 |
Transplant. Proc. |
pmid:15919458
|
Signorell J et al. |
Recurrent non-melanoma skin cancer: remission of field cancerization after conversion from calcineurin inhibitor- to proliferation signal inhibitor-based immunosuppression in a cardiac transplant recipient. |
2010 |
Transplant. Proc. |
pmid:21094874
|
Hayes D et al. |
Aerosolized tacrolimus: a case report in a lung transplant recipient. |
2010 |
Transplant. Proc. |
pmid:21094875
|
Hanafusa T et al. |
Long-term impact of hepatitis virus infection on kidney transplant recipients and a pilot study of the effects of interferon alpha on chronic hepatitis C. |
1995 |
Transplant. Proc. |
pmid:7533440
|
Yagihashi A et al. |
HLA matching effect in liver transplantation. |
1992 |
Transplant. Proc. |
pmid:1281569
|
Shapiro R et al. |
FK 506 in clinical kidney transplantation. |
1991 |
Transplant. Proc. |
pmid:1721361
|
Todo S et al. |
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. |
1991 |
Transplant. Proc. |
pmid:1703340
|
McCauley J et al. |
Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome. |
1991 |
Transplant. Proc. |
pmid:1721362
|
Zeevi A et al. |
Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection. |
1991 |
Transplant. Proc. |
pmid:1703341
|
Weis M et al. |
Impact of immunosuppression on coronary endothelial function after cardiac transplantation. |
1998 |
Transplant. Proc. |
pmid:9595131
|
Urbizu JM et al. |
Safety and efficacy of tacrolimus rescue therapy in 55 kidney transplant patients treated with cyclosporine. |
2003 |
Transplant. Proc. |
pmid:12962765
|
Zucker K et al. |
Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123027
|
Ronchetti F et al. |
Mucosal hyaluronic acid quantification in small bowel transplantation in pigs. |
1996 |
Transplant. Proc. |
pmid:8907950
|
Montagnino G et al. |
Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in kidney transplantation: twelve-month follow-up. |
2002 |
Transplant. Proc. |
pmid:12176515
|
Zmonarski S et al. |
Expression of PBMC TLR4 in Renal Graft Recipients Who Experienced Delayed Graft Function Reflects Dynamic Balance Between Blood and Tissue Compartments and Helps Select a Problematic Patient. |
|
Transplant. Proc. |
pmid:30056893
|
Terakura M et al. |
Effects of peritransplant administration of hematopoietic growth factors on the development of chronic allograft rejection. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083380
|
Song Z et al. |
FK 506 prevents islet xenograft rejection: a study in the pig-to-rat model. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083437
|
Inagaki K et al. |
Effects of FK506 and 15-deoxyspergualin in rat orthotopic liver transplantation. |
1989 |
Transplant. Proc. |
pmid:2468210
|
Scantlebury V et al. |
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. |
1991 |
Transplant. Proc. |
pmid:1721395
|
Lee S et al. |
Mycophenolic acid trough level measurements and clinical outcomes in kidney transplantation recipients on a fixed dose (1.5 g/d) of mycophenolate mofetil in Korea. |
2010 |
Transplant. Proc. |
pmid:20430174
|
Kim JM et al. |
Preemptive therapy in adult liver transplant recipients in CMV-endemic area. |
2010 |
Transplant. Proc. |
pmid:20430182
|
Ali IH et al. |
Incidence and risk factors for post-renal transplant diabetes mellitus. |
2011 |
Transplant. Proc. |
pmid:21440763
|
Hariharan S et al. |
Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123462
|
McGrath JS and Shehata M |
Chronic allograft nephropathy: prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution. |
2001 |
Transplant. Proc. |
pmid:11377500
|
Stratta RJ |
Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multi-center report. The FK/MMF Multi-Center Study Group. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123463
|
Baid S et al. |
Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection. |
2002 |
Transplant. Proc. |
pmid:12176569
|
Kelly JS and Sharkey J |
Immunosuppressants-ligands as neuroprotectants. |
2001 |
Transplant. Proc. |
pmid:11377506
|
Jonas S et al. |
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8962257
|
Akioka K et al. |
Diabetes in renal transplant recipients treated with tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176570
|
Mohacsi P et al. |
Immunosuppression in ABO-incompatible transplantation. |
2001 |
Transplant. Proc. |
pmid:11377508
|
Cai W et al. |
Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients. |
2018 |
Transplant. Proc. |
pmid:29735215
|
Kauffman HM et al. |
Drug regimens affect cadaveric kidney graft survival. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267176
|
Zhang J et al. |
Chemotherapy for De Novo Gastric Adenocarcinoma After Deceased Orthotopic Liver Transplantation: A Case Report. |
|
Transplant. Proc. |
pmid:28104131
|
Langrehr JM et al. |
Indefinite small bowel allograft survival after limited immunosuppressive therapy is not due to specific hyporesponsiveness. |
1991 |
Transplant. Proc. |
pmid:1721425
|
Zou XM et al. |
Immunosuppressive effect of FK506 on orthotopic liver and small bowel xenotransplantation (xenoOLTx and SBTx). |
1996 |
Transplant. Proc. |
pmid:8658729
|
Honbo T et al. |
The oral dosage form of FK-506. |
1987 |
Transplant. Proc. |
pmid:2445068
|
Ettenger RB |
New immunosuppressive agents in pediatric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9723350
|
Eun SC et al. |
Prolongation of the rat composite tissue allograft survival by the combination of tolerogenic immature dendritic cells and short-term treatment with FK506. |
2013 |
Transplant. Proc. |
pmid:23769045
|
Liu W et al. |
Transfusion of endothelial cells with lentivirus-mediated expression of fas ligand prolonged survival of rat liver allograft. |
2012 |
Transplant. Proc. |
pmid:22664023
|
Jain A et al. |
Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176649
|
Matevossian E et al. |
Nitric oxide inhibition and consecutive Aspisol application show a prolonged survival of orthotopic transplanted livers in a rat model. |
2008 |
Transplant. Proc. |
pmid:18555092
|
Groetzner J et al. |
Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up? |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267373
|
Kupferman JC et al. |
Activation of the renal renin-angiotensin system by cyclosporine A and FK 506 in the rat. |
1994 |
Transplant. Proc. |
pmid:7524224
|
van den Berg AP et al. |
Recurrent HCV infection reduces the requirement for tacrolimus after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267375
|
Kattner A et al. |
Conversion from CyA to CyA-NOF in a cholestatic liver grafted patient with CyA malabsorption. |
1994 |
Transplant. Proc. |
pmid:7524225
|
Mochizuki M et al. |
A multicenter clinical open trial of FK 506 in refractory uveitis, including Behçet's disease. Japanese FK 506 Study Group on Refractory Uveitis. |
1991 |
Transplant. Proc. |
pmid:1721456
|
Chávez R et al. |
Hepatotrophic effect of cyclosporine and FK 506 is not mimicked by rapamycin. |
1999 |
Transplant. Proc. |
pmid:10500655
|
Roat MI et al. |
Treatment of Cogan's syndrome with FK 506: a case report. |
1991 |
Transplant. Proc. |
pmid:1721457
|
EscartÃn A et al. |
Orthotopic small bowel transplantation in pigs without steroids. |
1999 |
Transplant. Proc. |
pmid:10500720
|
Meiser BM et al. |
Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft model. |
1992 |
Transplant. Proc. |
pmid:1384201
|
Ochiai T et al. |
Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat. |
1987 |
Transplant. Proc. |
pmid:2484094
|
Ginevri F et al. |
Expression of collagen by renal fibroblasts treated with FK 506 in vitro. |
1998 |
Transplant. Proc. |
pmid:9636387
|
Hutchinson IV et al. |
Differences in the mode of action of cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636388
|
Iwata H et al. |
Prolongation of xenograft survival by combining donor-specific intravenous presensitization with FK 506. |
2002 |
Transplant. Proc. |
pmid:12431592
|
Itagaki F et al. |
Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation. |
2002 |
Transplant. Proc. |
pmid:12431607
|
Zhang J et al. |
Value of CYP3A5 genotyping on determining initial dosages of tacrolimus for Chinese renal transplant recipients. |
2010 |
Transplant. Proc. |
pmid:21094797
|
Guleria S et al. |
Tacrolimus (Pan Graf) as de novo therapy in renal transplant recipients in India. |
2006 |
Transplant. Proc. |
pmid:16979989
|
Teng D et al. |
Comparison of rapamycin versus FK506 on expression of cytoprotective genes in the rat kidney allografts undergoing chronic allograft nephropathy. |
2006 |
Transplant. Proc. |
pmid:16980034
|
Takaya S et al. |
Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1703691
|
Budde K et al. |
Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months. |
1998 |
Transplant. Proc. |
pmid:9636503
|